CINCINNATI, April 10, 2019 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of
diagnostic testing solutions and life science raw materials will report second quarter 2019 financial results Tuesday, April 30,
2019.
Jack Kenny, Chief Executive Officer, and Eric Rasmussen, Chief Financial Officer, will host a conference call beginning at 10:00
a.m. Eastern Time to discuss the results and answer questions.
To participate in the live call by telephone from the U.S., dial (866) 443-5802, or from outside the U.S., dial (513) 360-6924,
and enter the audience pass code 3893028.
A replay will be available for 14 days beginning at 1:00 p.m. Eastern Time on April 30, 2019 by dialing (855) 859-2056 or (404)
537-3406 and entering pass code 3893028.
About Meridian Bioscience, Inc.
Meridian is a fully integrated life science company that develops, manufactures, markets and distributes a broad range of
innovative diagnostic products. We are dedicated to developing and delivering better solutions that give answers with speed,
accuracy and simplicity that are redefining the possibilities of life from discovery to diagnosis. Through discovery and
development, we provide critical life science raw materials used in immunological and molecular tests for human, animal, plant, and
environmental applications. Through diagnosis, we provide diagnostic solutions in areas including gastrointestinal and upper
respiratory infections and blood lead level testing. We build relationships and provide solutions to hospitals, reference
laboratories, research centers, veterinary testing centers, physician offices, diagnostics manufacturers, and biotech companies in
more than 70 countries around the world.
Meridian’s shares are traded on the NASDAQ Global Select Market, symbol VIVO. Meridian’s website address is
www.meridianbioscience.com.
Contact:
Eric Rasmussen
Chief Financial Officer
Meridian Bioscience, Inc.
Phone: 513.271.3700
Email: mbi@meridianbioscience.com
